Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro
(Q34793691)
scientific article
scientific article
Language:
other details
| description | scientific article |
External Links
| (P356) |
10.1073/PNAS.96.1.133
|
| (P698) |
9874784
|
| (P819) |
1999PNAS...96..133F
|
| (P932) |
15105
|
| (P5875) |
13413240
|